Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease
Abstract Introduction Heterogeneity of outcomes in Alzheimer's disease (AD) clinical trials necessitates large sample sizes and contributes to study failures. This analysis determined whether mild‐to‐moderate AD populations could be enriched for cognitive decline based on apolipoprotein (APOE)...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.04.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|